In a limited subset of patients, dupilumab-induced hypereosinophilia is persistent. Two-month follow-up eosinophil count may predict long-lasting hypereosinophilia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/alr.23212 | DOI Listing |
Publication Analysis
Top Keywords
eosinophil count
8
count predict
8
early increase
4
increase eosinophil
4
predict long-term
4
long-term hypereosinophilia
4
hypereosinophilia dupilumab
4
dupilumab treatment
4
treatment 2-year
4
2-year observational
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!